Filtros de búsqueda

Lista de obras de François Guilhot

11q13 rearrangement in B cell chronic lymphocytic leukemia

artículo científico publicado en 1997

A case of inv(5) in non-Hodgkin's lymphoma

artículo científico publicado en 1989

A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results

scientific article published on 01 January 1991

A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results

scientific article published on 01 January 1993

A penicillinase-producing Fusobacterium nucleatum strain isolated from blood culture

scientific article published on 01 December 1987

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

artículo científico publicado en 2013

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials

scientific article published on 13 October 2009

Acral erythema in children receiving high-dose methotrexate

scientific article published on 01 September 1999

Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup

artículo científico publicado en 2009

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia

artículo científico publicado en 2012

Agar human T cell colony growth promoted by a B + null cell-derived lymphokine distinct from IL 2

scientific article published on 01 April 1985

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients

artículo científico publicado en 2014

Age-related health care disparities in multiple myeloma.

artículo científico publicado en 2017

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

scientific article published on 01 October 1999

Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de Moelle

artículo científico publicado en 1995

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.

artículo científico publicado en 2013

Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity ⬇️

artículo científico publicado el 24 de septiembre de 2010

An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process.

artículo científico publicado en 2013

BCR-ABL activates STAT3 via JAK and MEK pathways in human cells

artículo científico publicado en 2006

BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients

artículo científico publicado en 2014

BCR/ABL promotes dendritic cell-mediated natural killer cell activation

artículo científico publicado en 2005

Bas les pattes!

artículo científico publicado en 1998

Beyond tyrosine kinase inhibitors: Combinations and other agents

artículo científico publicado en 2016

Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal response.

artículo científico publicado en 2011

Cardiotrophin-like cytokine labelling using Bir A biotin ligase: a sensitive tool to study receptor expression by immune and non-immune cells.

artículo científico publicado en 2005

Cat-scratch disease simulating a malignant process of the chest wall.

artículo científico publicado en 1999

Central nervous system relapses after autologous stem cell transplantation for myeloma. Report of two cases

artículo científico publicado en 1997

Central neurologic forms of Waldenström's disease. Bing-Neel syndrome. 3 cases

artículo científico publicado en 1991

Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate

artículo científico publicado en 1995

Characterization of the different BCR-ABL transcripts with a single multiplex RT-PCR.

artículo científico publicado en 2004

Chromosome 6p rearrangements appear to be secondary changes in various haematological malignancies

artículo científico publicado en 1989

Chronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches.

artículo científico

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

artículo científico publicado en 2001

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

artículo científico publicado en 2009

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

artículo científico publicado en 2007

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

artículo científico publicado en 2009

Combined therapy interferon and chemotherapy in chronic myelogenous leukemia

artículo científico publicado en 1989

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

artículo científico publicado en 2002

Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML

scientific article published on 01 April 2004

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM) ⬇️

artículo científico publicado el 15 de octubre de 1997

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients

artículo científico publicado en 2015

Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemia

artículo científico publicado en 2010

Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.

artículo científico publicado en 2003

Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.

artículo científico publicado en 2006

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

artículo científico publicado en 2016

Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia

scientific article published on 01 October 1996

Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia.

artículo científico publicado en 2016

Curing chronic myeloid leukemia

artículo científico publicado en 2012

Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia

scientific article published on 01 May 1996

Current treatment strategies in chronic myeloid leukemia.

artículo científico

Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC)

artículo científico publicado en 1997

Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside.

artículo científico publicado en 1991

Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.

artículo científico publicado en 1993

Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapy

artículo científico publicado en 1990

Cytogenetics in CML: more important than you think.

artículo científico publicado en 2016

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

artículo científico publicado en 2006

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

article

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet

artículo científico

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

artículo científico publicado en 2013

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

artículo científico publicado en 2002

Detection of epsilon class switching and IgE synthesis in human B cells.

artículo científico publicado en 2006

Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias

scientific article published on 01 June 1994

Development of chorea with lupus anticoagulant after interferon therapy

artículo científico publicado en 1996

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

artículo científico publicado en 2016

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

artículo científico publicado en 2010

Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon alpha therapy?

artículo científico publicado en 1998

Double-intensive therapy in high-risk multiple myeloma.

artículo científico publicado en 1992

E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype

artículo científico publicado en 2002

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)

scientific article published on 01 May 1997

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

artículo científico publicado en 2013

Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia

artículo científico publicado en 2014

Effects of sCD23 on proliferation of leukemic cells from a patient with chronic myelogenous leukemia during blast crisis.

artículo científico publicado en 1993

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

artículo científico publicado en 2009

Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

artículo científico publicado en 2016

Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon.

artículo científico publicado en 1993

Enhanced NK activity during blast crisis in chronic myelogenous leukemia (CML)

artículo científico publicado en 1992

Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid

artículo científico publicado en 2017

Erratum: Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

scholarly article published in Cancer

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

artículo científico publicado en 2013

Evaluation of beta-catenin activating mutations in chronic myeloid leukemia

artículo científico publicado en 2007

Evidence for BCR‐ABL‐dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients ⬇️

artículo científico publicado el 1 de julio de 2012

Evidence for eomesodermin-expressing innate-like CD8(+) KIR/NKG2A(+) T cells in human adults and cord blood samples

artículo científico publicado en 2015

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

artículo científico publicado en 2006

Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy

artículo científico publicado en 2005

Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia.

artículo científico publicado en 2006

Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia ⬇️

artículo científico publicado el 7 de octubre de 2010

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment

artículo científico publicado en 2007

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

artículo científico publicado en 2012

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

artículo científico publicado en 2006

Fluctuation of a clone 46,XX,i(7q) in bone marrow in a Fanconi anaemia

scientific article published on 01 September 1986

Four additional cases of trisomy 14 as the sole anomaly in various haematological malignancies.

artículo científico publicado en 1992

Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy

artículo científico publicado en 2002

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia

artículo científico publicado en 2015

Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients

artículo científico publicado en 2010

Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia

artículo científico publicado en 1997

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

artículo científico publicado en 2002

Hematology: dasatinib regimens for patients with chronic myeloid leukemia.

artículo científico publicado en 2009

Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

artículo científico publicado en 2015

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients

scientific article published on October 2013

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS.

artículo científico publicado en 2015

High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial

artículo científico

High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease

artículo científico publicado en 1992

Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)

artículo científico publicado en 2001

Identification of several genes differentially expressed during progression of chronic myelogenous leukemia.

artículo científico publicado en 1998

IgG subclass deficiency in acute myeloid leukemia

scientific article published on 01 January 1989

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

artículo científico publicado en 2003

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

artículo científico publicado en 2003

Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: rationale and design of phase I/II trials

artículo científico publicado en 2003

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

artículo científico publicado en 2002

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia

artículo científico publicado en 2010

Improvement of cytogenetic results in B-cell chronic lymphocytic leukemia using immuno-purified leukemic cells

scientific article published on 01 February 1993

Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient

artículo científico publicado en 2006

Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84) ⬇️

artículo científico publicado el 1 de noviembre de 1991

Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group

scientific article published on 01 July 1993

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

artículo científico publicado en 1997

Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase

artículo científico publicado en 1998

Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model.

artículo científico publicado en 2014

Interferons and hematology

artículo científico publicado en 2002

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

artículo científico publicado en 2013

Isochromosome 8q: a new recurring secondary anomaly in adults with B-lineage acute lymphoid leukemia

scientific article published on 01 March 1994

Karyotype evolution in the bone marrow of a patient with Fanconi anemia: breakpoints in clonal anomalies of this disease

artículo científico publicado en 1988

Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemia.

artículo científico publicado en 1989

Legionnaires' disease with multivisceral involvement during the treatment of Burkitt's leukemia

scientific article published on 01 March 1989

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion.

artículo científico publicado en 2015

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease ⬇️

artículo científico publicado el 25 de julio de 2011

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

artículo científico publicado en 2016

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

artículo científico publicado en 2017

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl

artículo científico publicado en 2001

Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation

scientific article published on 17 February 2007

Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study

artículo científico publicado en 2014

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

artículo científico publicado en 2010

Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) st

artículo científico publicado en 2014

Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study

artículo científico publicado en 2012

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease

artículo científico publicado en 2013

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellu

artículo científico publicado en 2009

Malignant histiocytosis: a specific t(2;5)(p23;q35) translocation? Review of the literature ⬇️

artículo científico publicado el 1 de septiembre de 1988

Model-based inference and classification of immunological control mechanisms from TKI cessation and dose reduction in CML patients

artículo científico publicado en 2020

Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemia

artículo científico publicado en 1994

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

artículo científico publicado en 2011

Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry

artículo científico publicado en 2015

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)

artículo científico publicado en 2006

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

artículo científico publicado en 2010

Myelocytosis in adults. Diagnostic orientation

artículo científico publicado el 1 de abril de 1992

NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

artículo científico publicado en 2018

Nosocomial legionnaires' disease in a bone marrow transplant unit.

artículo científico publicado en 1991

Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex

artículo científico publicado en 2015

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.

artículo científico publicado en 2008

Osteopontin is upregulated by BCR-ABL

artículo científico publicado en 2005

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

artículo científico publicado en 2003

Ovarian sarcoma and acute myelogenous leukaemia

scientific article published on 01 January 2001

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

scientific article published on 01 January 2000

Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission.

artículo científico publicado en 2001

Ph: not bad at all ⬇️

artículo científico publicado el 23 de junio de 2011

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati

artículo científico publicado en 2009

Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

artículo científico publicado en 2017

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

artículo científico publicado en 2016

Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial

artículo científico publicado en 2012

Polycythemia vera. Diagnostic orientation

artículo científico publicado el 1 de marzo de 1992

Polymerase chain reaction detection of residual disease in chronic myeloid leukemia patients in complete cytogenetic remission under interferon with or without chemotherapy

artículo científico publicado en 1992

Ponatinib and platelets a conflict in CML

scientific article published on 01 April 2019

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial

artículo científico publicado en 2018

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

artículo científico publicado en 2016

Possible prevention of Pneumocystis carinii pneumonia by pentamidine aerosol after bone marrow transplantation

artículo científico publicado en 1991

Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia

artículo científico publicado en 1995

Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia pos

artículo científico publicado en 2008

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016.

artículo científico publicado en 2017

Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.

artículo científico publicado en 2003

Prognosis of chronic myeloid leukemia

artículo científico publicado el 2 de febrero de 1991

Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy.

artículo científico publicado en 2008

Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia

artículo científico publicado en 2002

Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy

artículo científico publicado el 1 de diciembre de 1992

Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML).

artículo científico publicado en 2008

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

artículo científico publicado en 2017

Rapid clinical improvement of peripheral artery occlusive disease symptoms after nilotinib discontinuation despite persisting vascular occlusion.

artículo científico publicado en 2014

Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system.

artículo científico publicado en 2010

Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle.

artículo científico publicado en 1995

Recurrence of childhood acute lymphoblastic leukemia presenting as a tumor of the middle ear: a case report

scientific article published on 01 July 1997

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2013

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC

artículo científico publicado en 2011

Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study

artículo científico publicado en 1987

Reply to J. Richter et al.

artículo científico publicado en 2014

Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia

artículo científico publicado en 2006

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily

artículo científico

Self-renewal and maturation of immature T-cell progenitors within PHA-induced agar T-cell colonies

scientific article published on 01 January 1984

Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML

artículo científico publicado en 2006

Single versus double autologous stem-cell transplantation for multiple myeloma.

artículo científico publicado en 2003

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

artículo científico publicado en 2009

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial

artículo científico publicado en 1999

Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.

artículo científico publicado en 2009

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation

scientific article published on 01 October 1999

T lymphocyte growth factor as a regulatory molecular for the growth and function of T lymphocytes

artículo científico publicado en 1982

Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages

scientific article published on 01 February 1998

The 8p11 anomaly in "monoblastic" leukaemia

scientific article published on 01 January 1988

The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge ⬇️

artículo científico publicado el 1 de octubre de 2010

The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia.

artículo científico publicado en 2016

The Patient Journey in Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Therapies: Qualitative Insights Using a Global Ethnographic Approach ⬇️

artículo científico publicado el 1 de enero de 2013

The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia

artículo científico publicado en 2016

The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).

artículo científico publicado en 2010

The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.

artículo científico publicado en 2015

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells

artículo científico publicado en 2007

The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase

artículo científico publicado en 1994

The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group

scientific article published on 01 May 1996

Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia

scientific article published on 01 June 2005

Three cases of myelodysplastic-myeloproliferative disorder with abnormal chromatin clumping in granulocytes

artículo científico publicado en 1989

Thrombocytosis. Diagnostic orientation

artículo científico publicado el 1 de febrero de 1992

Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia.

artículo científico publicado en 2000

Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea

scientific article published on 01 August 1988

Treatment of chronic myeloid leukemia with alpha interferons

artículo científico publicado el 1 de enero de 1991

Two cases of t(4;11) acute lymphoblastic leukemia (ALL) following ALL without the t(4;11): second or secondary leukemias?

scientific article published on 01 September 1991

Unclassifiable high grade malignant T-cell lymphoma with clonal evolution

artículo científico publicado en 1994

Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis.

artículo científico publicado en 2016

[Acute leukemia with translocation (8;16)]

artículo científico publicado en 1988

[Cerebral meningioma associated with thrombocytosis]

artículo científico publicado en 1987

[Chronic myeloid leukemia. Diagnosis, treatment]

artículo científico publicado en 1993

[First-line treatment of severe myelomas of the young subject by high-dose melphalan]

artículo científico publicado en 1988

[Homonymous lateral hemianopsia revealing cerebral thrombophlebitis. Role of a deficiency of protein S induced by l-asparaginase]

artículo científico publicado en 2001

[Hypercalcemia in essential hypereosinophilic syndrome]

scientific article published on 01 January 1996

[Interferon-alpha in the treatment of chronic myeloid leukemia]

artículo científico publicado en 1999

[Interferons. Treatment of malignant hemopathies with interferons]

scientific article published on 01 January 1993

[Rearrangement of the short arm of chromosome 12 in chronic myelomonocytic leukemias]

scientific article published on 01 January 1987

[The treatment of chronic myeloid leukemia in chronic phase with interferons]

artículo científico publicado en 1988

[Therapeutic leukapheresis in a leukostasis syndrome complicating chronic lymphoid leukemia]

artículo científico publicado en 1988

[Thrombosis of the superior vena cava despite severe thrombopenia]

artículo científico publicado en 1987

[Treatment of chronic myeloid leukemia]

scientific article published on 01 June 1993

[Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol]

artículo científico publicado en 1989

p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia

artículo científico publicado en 2003

p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).

artículo científico publicado en 2004

t(3;17)(q21;q25) in Epstein-Barr virus associated peripheral T-cell lymphoma: a paediatric case.

artículo científico publicado en 1998

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda